• Home |
  • Careers |
  • Contact |
  • Subscription |
  • Site map |
  • Français |
  • Text size: A A A
Ambrilia Biopharma
  • About
    • + Vision & strategy
    • + Management
    • + Board of directors
    • + Scientific advisory board
  • Investors
    • + Presentations and webcasts
    • + Shareholder information
    • + Stock information
    • + Financial reports
    • + Corporate governance
    • + Analysts
    • + Sustainability
    • + Investor contact
  • News & Events
    • + News
    • + Events
    • + Media room
  • Pipeline
    • + Acromegaly - Octreotide
    • + Prostate cancer - PCK3145
    • + Prostate cancer - Goserelin
    • + Cancer - NGR-Delivery Technology
    • + HIV/AIDS - Protease Inhibitors
    • + HIV/AIDS - Integrase Inhibitors
    • + HIV/AIDS - Entry Inhibitors
    • + HCV - Polymerase Inhibitors
    • + HCV - Entry Inhibitors
    • + Influenza A - M2 Proton Channel Inhibitors
    • + Diagnostic - PSP94
    • + Diagnostic - Colopath® / ColorectAlert™
  • Scientific library
  • Partnerships
    • + Our partners
    • + Partnership / Divestment Opportunities

Site map

  • About
    • + Vision & strategy
    • + Management
    • + Board of directors
    • + Scientific advisory board
  • Investors
    • + Presentations and webcasts
    • + Shareholder information
    • + Stock information
    • + Financial reports
    • + Corporate governance
    • + Analysts
    • + Sustainability
    • + Investor contact
  • News & Events
    • + News
    • + Events
    • + Media room
  • Pipeline
    • + Acromegaly - Octreotide
    • + Prostate cancer - PCK3145
    • + Prostate cancer - Goserelin
    • + Cancer - NGR-Delivery Technology
    • + HIV/AIDS - Protease Inhibitors
    • + HIV/AIDS - Integrase Inhibitors
    • + HIV/AIDS - Entry Inhibitors
    • + HCV - Polymerase Inhibitors
    • + HCV - Entry Inhibitors
    • + Influenza A - M2 Proton Channel Inhibitors
    • + Diagnostic - PSP94
    • + Diagnostic - Colopath® / ColorectAlert™
  • Scientific library
  • Partnerships
    • + Our partners
    • + Partnership / Divestment Opportunities
  • Careers
  • Contact

Copyright © 1998-2008 Ambrilia Biopharma. All rights reserved. - Terms of use - Forward looking statement